Headlands Technologies’s BioNTech BNTX Stock Holding History

Headlands Technologies’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.52M	Buy	+27,087	New	+$2.55M	0.27%	95
2026 Q1	–	Sell	-19,914	Closed	-$1.9M	–	748
2025 Q4	$1.9M	Buy	+19,914	New	+$2.01M	0.16%	149
2023 Q3	–	Sell	-2,731	Closed	-$295K	–	939
2023 Q2	$295K	Buy	2,731 +1,802	+194%	+$203K	0.09%	223
2023 Q1	$116K	Buy	929 +877	+1,687%	+$120K	0.08%	170
2022 Q4	$8K	Buy	+52	New	+$8K	0.01%	365

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Headlands Technologies's BNTX Position: Q2 2026 in Review

Headlands Technologies opened a new position in BioNTech (BNTX) in Q2 2026: 27,087 shares worth $2.52M. The stake represents 0.27% of the portfolio and ranks #95 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in BNTX as recently as Q4 2025.

Headlands Technologies first reported a position in BNTX in Q4 2022 and has held it in 5 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Headlands Technologies held 27,087 shares of BioNTech worth $2.52M as of Q2 2026.
BioNTech was a new Headlands Technologies position in Q2 2026.
BioNTech made up 0.27% of Headlands Technologies's portfolio in Q2 2026, its #95 holding.
Headlands Technologies first reported a position in BioNTech in Q4 2022 and has held it in 5 quarters since.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.